MesenchimaleCellule staminali for Progressive Multiple Sclerosis_Sweden

To assess the safety of a single dose of IV infusion of bone-marrow derived autologous Mesenchymal Stem Cells (MSCS) in Multiple Sclerosis (SM) with progressive disease status.


Nbscience

Organizzazione di ricerca a contratto